Secondary
G1 Therapeutics, Inc.
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for the treatment of patients with cancer.
Symbol
GTHX
Last Closing Price
$25.10
Anticipated Date
TBD
Underwriters
J.P. Morgan, Cowen
To view the prospectus for G1 Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277